The role and applications of extracellular vesicles in osteoporosis

Abstract

Osteoporosis is a widely observed condition characterized by the systemic deterioration of bone mass and microarchitecture, which increases patient susceptibility to fragile fractures. The intricate mechanisms governing bone homeostasis are substantially impacted by extracellular vesicles (EVs), which play crucial roles in both pathological and physiological contexts. EVs derived from various sources exert distinct effects on osteoporosis. Specifically, EVs released by osteoblasts, endothelial cells, myocytes, and mesenchymal stem cells contribute to bone formation due to their unique cargo of proteins, miRNAs, and cytokines. Conversely, EVs secreted by osteoclasts and immune cells promote bone resorption and inhibit bone formation. Furthermore, the use of EVs as therapeutic modalities or biomaterials for diagnosing and managing osteoporosis is promising. Here, we review the current understanding of the impact of EVs on bone homeostasis, including the classification and biogenesis of EVs and the intricate regulatory mechanisms of EVs in osteoporosis. Furthermore, we present an overview of the latest research progress on diagnosing and treating osteoporosis by using EVs. Finally, we discuss the challenges and prospects of translational research on the use of EVs in osteoporosis.

References

1. Aparisi Gómez, M. P., Aparisi, F., Guglielmi, G. & Bazzocchi, A. in Imaging in Geriatrics (eds G. Guglielmi & M. Maas) 367-395
(Springer International Publishing, 2023)..
2. Dimai H. P.& Fahrleitner-Pammer, A. Osteoporosis and fragility fractures: currently available pharmacological options and future directions. Best. Pr. Res. Clin. Rheumatol. 36, 101780(2022).
3. Mitchell P. J., Chan D.-C., Lee J.-K., Tabu I.& Alpuerto, B. B. The global burden of fragility fractures - what are the differences, and where are the gaps. Best. Pr. Res. Clin. Rheumatol. 36, 101777(2022).
4. Xue, F.et al.7,8-Dihydroxyflavone modulates bone formation and resorption and ameliorates ovariectomy-induced osteoporosis. eLife 10, e64872 (2021).
5. Palacios, S. Medical treatment of osteoporosis. Climacteric 25, 43-49 (2022).
6. Zhou, S., Huang, G.& Chen, G. Synthesis and biological activities of drugs for the treatment of osteoporosis. Eur. J. Med. Chem. 197, 112313(2020).
7. Khosla S.& Hofbauer, L. C. Osteoporosis treatment: recent developments and ongoing challenges. Lancet Diabetes Endocrinol. 5, 898-907 (2017).
8. Yang, Q.et al.Role of extracellular vesicles in osteosarcoma. Int. J. Med. Sci. 19, 1216-1226 (2022).
9. Zijlstra A.& Di Vizio, D. Size matters in nanoscale communication. Nat. Cell Biol. 20, 228-230 (2018).
10. Fujita, Y., Yoshioka, Y.& Ochiya, T. Extracellular vesicle transfer of cancer pathogenic components. Cancer Sci. 107, 385-390 (2016).
11. Han C., Yang J., Sun J.& Qin, G. Extracellular vesicles in cardiovascular disease: biological functions and therapeutic implications. Pharm. Ther. 233, 108025(2022).
12. Li, T.et al.Matrix vesicles as a therapeutic target for vascular calcification. Front. Cell Dev. Biol. 10, 825622(2022).
13. Wang S. E.Extracellular vesicles in cancer therapy. Semin. Cancer Biol. 86, 296-309 (2022).
14. Jiang, Y.et al.Engineered extracellular vesicles for bone therapy. Nano Today 44, 101487 (2022).
15. Cheng L.& Hill, A. F. Therapeutically harnessing extracellular vesicles. Nat. Rev. Drug Discov. 21, 379-399 (2022).
16. Zhang W., Huang P., Lin J.& Zeng, H. The role of extracellular vesicles in osteoporosis: a scoping review. Membranes 12, 324 (2022).
17. Mueller, S. K., Nocera, A. L.& Bleier, B. S. Exosome function in aerodigestive mucosa. Nanomed.: Nanotechnol. Biol. Med. 14, 269-277 (2018).
18. Rädler J., Gupta D., Zickler A.& Andaloussi, S. E. L. Exploiting the biogenesis of extracellular vesicles for bioengineering and therapeutic cargo loading. Mol. Ther. 31, 1231-1250 (2023).
19. Fordjour F. K., Guo C., Ai Y., Daaboul G. G.& Gould, S. J. A shared, stochastic pathway mediates exosome protein budding along plasma and endosome membranes. J. Biol. Chem. 298, 102394(2022).
20. Mathieu, M.et al.Specificities of exosome versus small ectosome secretion revealed by live intracellular tracking of CD63 and CD9. Nat. Commun. 12, 4389(2021).
21. Jin, Y.et al.Extracellular signals regulate the biogenesis of extracellular vesicles. Biol. Res. 55, 35(2022).
22. Schöneberg J., Lee I.-H., Iwasa J. H.& Hurley, J. H. Reverse-topology membrane scission by the ESCRT proteins. Nat. Rev. Mol. Cell Biol. 18, 5-17 (2017).
23. Vietri, M., Radulovic, M.& Stenmark, H. The many functions of ESCRTs. Nat. Rev. Mol. Cell Biol. 21, 25-42 (2020).
24. Bache K. G., Brech A., Mehlum A.& Stenmark, H. Hrs regulates multivesicular body formation via ESCRT recruitment to endosomes. J. Cell Biol. 162, 435-442 (2003).
25. Teo, H.et al. ESCRT-I core and ESCRT-II GLUE domain structures reveal role for GLUE in linking to ESCRT-I and membranes. Cell 125, 99-111 (2006).
26. Wollert T., Wunder C., Lippincott-Schwartz, J. & Hurley, J. H. Membrane scission by the ESCRT-III complex. Nature 458, 172-177 (2009).
27. Stuffers S., Sem Wegner C., Stenmark, H. & Brech, A. Multivesicular endosome biogenesis in the absence of ESCRTs. Traffic 10, 925-937 (2009).
28. Perez-Hernandez, D. et al. The intracellular interactome of tetraspanin-enriched microdomains reveals their function as sorting machineries toward exosomes. J. Biol. Chem. 288, 11649-11661 (2013).
29. Hemler M. E.Tetraspanin proteins mediate cellular penetration, invasion, and fusion events and define a novel type of membrane microdomain. Annu. Rev. Cell Dev. Biol. 19, 397-422 (2003).
30. Clancy, J. W., Schmidtmann, M.& D'Souza-Schorey, C. The ins and outs of microvesicles. FASEB BioAdv. 3, 399-406 (2021).
31. Matusek, T.et al. The ESCRT machinery regulates the secretion and long-range activity of Hedgehog. Nature 516, 99-103 (2014).
32. Mathieu M.,Martin-Jaular, L., Lavieu, G. & Théry, C. Specificities of secretion and uptake of exosomes and other extracellular vesicles for cell-to-cell communication. Nat. Cell Biol. 21, 9-17 (2019).
33. Trajkovic, K.et al. Ceramide triggers budding of exosome vesicles into multivesicular endosomes. Science 319, 1244-1247 (2008).
34. Antonyak, M. A., Wilson, K. F. & Cerione, R. A. R(h)oads to microvesicles. Small GTPases 3, 219-224 (2012).
35. Li B., Antonyak M. A., Zhang, J. & Cerione, R. A. RhoA triggers a specific signaling pathway that generates transforming microvesicles in cancer cells. Oncogene 31,4740-4749 (2012).
36. Schlienger, S., Campbell, S. & Claing, A. ARF1 regulates the Rho/MLC pathway to control EGF-dependent breast cancer cell invasion. Mol. Biol. Cell 25, 17-29 (2014).
37. Muralidharan-Chari, V. et al. ARF6-regulated shedding of tumor cell-derived plasma membrane microvesicles. Curr. Biol. 19, 1875-1885 (2009).
38. Saheera, S., Potnuri, A. G.& Krishnamurthy, P. Nano-Vesicle (Mis)communication in senescence-related pathologies. Cells 9, 1974 (2020).
39. Charest A.Experimental and biological insights from proteomic analyses of extracellular vesicle cargos in normalcy and disease. Adv. Biosyst. 4, 2000069(2020).
40. Blander J. M.The many ways tissue phagocytes respond to dying cells. Immunol. Rev. 277, 158-173 (2017).
41. Gebara, N.et al.Extracellular vesicles, apoptotic bodies and mitochondria: stem cell bioproducts for organ regeneration. Curr. Transpl. Rep. 7, 105-113 (2020).
42. Radic M.Clearance of apoptotic bodies, NETs, and biofilm DNA: implications for autoimmunity. Front. Immunol. 5, 00365(2014).
43. Phan, T. K., Ozkocak, D. C.& Poon, I. K. H. Unleashing the therapeutic potential of apoptotic bodies. Biochem. Soc. Trans. 48, 2079-2088 (2020).
44. Teng F.& Fussenegger, M. Shedding light on extracellular vesicle biogenesis and bioengineering. Adv. Sci. 8, 2003505(2021).
45. Raposo, G.et al.B lymphocytes secrete antigen-presenting vesicles. J. Exp. Med. 183, 1161-1172 (1996).
46. Zitvogel, L.et al.Eradication of established murine tumors using a novel cellfree vaccine: dendritic cell derived exosomes. Nat. Med. 4, 594-600 (1998).
47. Izquierdo, E.et al. Extracellular vesicles and PD-L1 suppress macrophages, inducing therapy resistance in TP53-deficient B-cell malignancies. Blood 139, 3617-3629 (2022).
48. Lee, C.-H.et al. Macitentan improves antitumor immune responses by inhibiting the secretion of tumor-derived extracellular vesicle PD-L1. Theranostics 12, 1971-1987 (2022).
49. Antonyak, M. A.et al. Cancer cell-derived microvesicles induce transformation by transferring tissue transglutaminase and fibronectin to recipient cells. Proc. Natl. Acad. Sci. USA 108, 4852-4857 (2011).
50. Christianson H. C., Svensson K. J., van Kuppevelt T. H., Li, J.-P. & Belting, M. Cancer cell exosomes depend on cell-surface heparan sulfate proteoglycans for their internalization and functional activity. Proc. Natl. Acad. Sci. USA 110, 17380-17385 (2013).
51. Morelli, A. E.et al. Endocytosis, intracellular sorting,processing of exosomes by dendritic cells. Blood 104, 3257-3266 (2004).
52. Edgar J. R., Manna P. T., Nishimura S., Banting G.& Robinson, M. S. Tetherin is an exosomal tether. eLife 5, e17180 (2016).
53. Eitan E., Suire C., Zhang S.& Mattson, M. P. Impact of lysosome status on extracellular vesicle content and release. Ageing Res. Rev. 32, 65-74 (2016).
54. Tian T., Wang Y., Wang H., Zhu Z.& Xiao, Z. Visualizing of the cellular uptake and intracellular trafficking of exosomes by live-cell microscopy. J. Cell Biochem. 111, 488-496 (2010).
55. Murphy, D. E.et al.Extracellular vesicle-based therapeutics: natural versus engineered targeting and trafficking. Exp. Mol. Med. 51, 1-12 (2019).
56. Chen Y., Zhao Y., Yin Y., Jia, X. & Mao, L. Mechanism of cargo sorting into small extracellular vesicles. Bioengineered 12,8186-8201 (2021).
57. Wei, H.et al.Regulation of exosome production and cargo sorting. Int. J. Biol. Sci. 17, 163-177 (2021).
58. Szabó-Taylor, K. et al. Oxidative and other posttranslational modifications in extracellular vesicle biology. Semin. Cell Dev. Biol. 40, 8-16 (2015).
59. Dixson A. C., Dawson T. R., Di Vizio, D. & Weaver, A. M. Context-specific regulation of extracellular vesicle biogenesis and cargo selection. Nat. Rev. Mol. Cell Biol. 24, 454-476 (2023).
60. Fabbiano, F.et al.RNA packaging into extracellular vesicles: an orchestra of RNA-binding proteins? J. Extracell. Vesicles 10, e12043 (2020).
61. Villarroya-Beltri, C. et al. Sumoylated hnRNPA2B1 controls the sorting of miRNAs into exosomes through binding to specific motifs. Nat. Commun. 4, 2980(2013).
62. Robinson, H.et al.Caveolin-1-driven membrane remodelling regulates hnRNPKmediated exosomal microRNA sorting in cancer. Clin. Transl. Med. 11, e381(2021).
63. Liu, X.-M., Ma, L.& Schekman, R. Selective sorting of microRNAs into exosomes by phase-separated YBX1 condensates. eLife 10, e71982 (2021).
64. Teng, Y.et al.MVP-mediated exosomal sorting of miR-193a promotes colon cancer progression. Nat. Commun. 8, 14448(2017).
65. Barman, B.et al. VAP-A and its binding partner CERT drive biogenesis of RNAcontaining extracellular vesicles at ER membrane contact sites. Dev. Cell 57, 974-994.e978 (2022).
66. Lázaro-Ibáñez, E. et al. DNA analysis of low- and high-density fractions defines heterogeneous subpopulations of small extracellular vesicles based on their DNA cargo and topology. J. Extracell. Vesicles 8, 1656993 (2019).
67. Takahashi, A.et al.Exosomes maintain cellular homeostasis by excreting harmful DNA from cells. Nat. Commun. 8, 15287(2017).
68. Vagner, T.et al.Large extracellular vesicles carry most of the tumour DNA circulating in prostate cancer patient plasma. J. Extracell. Vesicles 7, 1505403 (2018).
69. Yokoi, A.et al.Mechanisms of nuclear content loading to exosomes. Sci. Adv. 5, eaax8849 (2019).
70. Rabas, N.et al.PINK1 drives production of mtDNA-containing extracellular vesicles to promote invasiveness. J. Cell Biol. 220, e202006049(2021).
71. Ramirez, M. I.et al. Technical challenges of working with extracellular vesicles. Nanoscale 10, 881-906 (2018).
72. Zhang, Y.et al.Exosome: a review of its classification, isolation techniques, storage, diagnostic and targeted therapy applications. Int. J. Nanomed. 15, 6917-6934 (2020).
73. D'Acunzo, P.et al. Isolation of mitochondria-derived mitovesicles and subpopulations of microvesicles and exosomes from brain tissues. Nat. Protoc. 17, 2517-2549 (2022).
74. De Sousa, K. P. et al. Isolation and characterization of extracellular vesicles and future directions in diagnosis and therapy. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 15, e1835(2023).
75. Monguió-Tortajada, M., Gálvez-Montón, C., Bayes-Genis, A., Roura, S. & Borràs, F. E. Extracellular vesicle isolation methods: rising impact of size-exclusion chromatography. Cell. Mol. Life Sci. 76, 2369-2382 (2019).
76. Kaddour, H., Tranquille, M.& Okeoma, C. M. The past, the present, and the future of the size exclusion chromatography in extracellular vesicles separation. Viruses 13, 2272 (2021).
77. Jalaludin, I., Lubman, D. M.& Kim, J. A guide to mass spectrometric analysis of extracellular vesicle proteins for biomarker discovery. Mass Spectrom. Rev. 42, e21749(2023).
78. Gámez-Valero, A. et al. Size-exclusion chromatography-based isolation minimally alters extracellular vesicles' characteristics compared to precipitating agents. Sci. Rep. 6, 33641(2016).
79. Taylor, D. D. & Shah, S. Methods of isolating extracellular vesicles impact downstream analyses of their cargoes. Methods 87, 3-10 (2015).
80. Mol E. A., Goumans M.-J., Doevendans P. A., Sluijter J. P.G. & Vader, P. Higher functionality of extracellular vesicles isolated using size-exclusion chromatography compared to ultracentrifugation. Nanomed.: Nanotechnol. Biol. Med. 13, 2061-2065 (2017).
81. Liangsupree, T., Multia, E.& Riekkola, M.-L. Modern isolation and separation techniques for extracellular vesicles. J. Chromatogr. A 1636, 461773 (2021).
82. Karimi, N.et al.Detailed analysis of the plasma extracellular vesicle proteome after separation from lipoproteins. Cell. Mol. Life Sci. 75, 2873-2886 (2018).
83. Sódar, B. W.et al.Low-density lipoprotein mimics blood plasma-derived exosomes and microvesicles during isolation and detection. Sci. Rep. 6, 24316(2016).
84. Woo, H.-K.et al. Characterization and modulation of surface charges to enhance extracellular vesicle isolation in plasma. Theranostics 12, 1988-1998 (2022).
85. Ter-Ovanesyan, D. et al. Improved isolation of extracellular vesicles by removal of both free proteins and lipoproteins. eLife 12, e86394 (2023).
86. Hassanpour Tamrin, S., Sanati Nezhad, A. & Sen, A. Label-free isolation of exosomes using microfluidic technologies. ACS Nano 15, 17047-17079 (2021).
87. Zhang, S.et al.Advanced microfluidic technologies for isolating extracellular vesicles. TrAC Trend Anal. Chem. 157, 116817(2022).
88. Zhang, P.et al.Ultrasensitive detection of circulating exosomes with a 3Dnanopatterned microfluidic chip. Nat. Biomed. Eng. 3, 438-451 (2019).
89. Liang, M.et al. Osteoclast-derived small extracellular vesicles induce osteogenic differentiation via inhibiting ARHGAP1. Mol. Ther. Nucleic Acids 23, 1191-1203 (2021).
90. Ikebuchi, Y.et al. Coupling of bone resorption and formation by RANKL reverse signalling. Nature 561, 195-200 (2018).
91. Ma, Q.et al.Osteoclast-derived apoptotic bodies couple bone resorption and formation in bone remodeling. Bone Res. 9, 5(2021).
92. Yang J.-X., Xie P., Li Y.-S., Wen T.& Yang, X.-C. Osteoclast-derived miR-23a-5pcontaining exosomes inhibit osteogenic differentiation by regulating Runx2. Cell. Signal. 70, 109504(2020).
93. Li, D.et al.Osteoclast-derived exosomal miR-214-3p inhibits osteoblastic bone formation. Nat. Commun. 7, 10872(2016).
94. Sun, W.et al.Osteoclast-derived microRNA-containing exosomes selectively inhibit osteoblast activity. Cell Discov. 2, 16015(2016).
95. Morhayim, J., Rudjito, R., van Leeuwen, J. P. & van Driel, M. Paracrine signaling by extracellular vesicles via osteoblasts.Curr. Mol. Biol. Rep. 2, 48-55 (2016).
96. Davies, O. G.et al.Annexin-enriched osteoblast-derived vesicles act as an extracellular site of mineral nucleation within developing stem cell cultures. Sci. Rep. 7, 12639(2017).
97. de Souza, W.et al. Titanium dioxide nanoparticles affect osteoblast-derived exosome cargos and impair osteogenic differentiation of human mesenchymal stem cells. Biomater. Sci. 11, 2427-2444 (2023).
98. Niedermair, T.et al.Influence of extracellular vesicles isolated from osteoblasts of patients with Cox-Arthrosis and/or osteoporosis on metabolism and osteogenic differentiation of BMSCs. Front. Bioeng. Biotechnol. 8, 615520(2020).
99. Wang Q., Shen X., Chen Y., Chen J.& Li, Y. Osteoblasts-derived exosomes regulate osteoclast differentiation through miR-503-3p/Hpse axis. Acta Histochem. 123, 151790(2021).
100. Deng, L.et al. Osteoblast-derived microvesicles: a novel mechanism for communication between osteoblasts and osteoclasts. Bone 79, 37-42 (2015).
101. Wang, W.et al.Circ_0008542 in osteoblast exosomes promotes osteoclast-induced bone resorption through m6A methylation. Cell Death Dis. 12, 628(2021).
102. Uenaka, M.et al.Osteoblast-derived vesicles induce a switch from boneformation to bone-resorption in vivo. Nat. Commun. 13, 1066(2022).
103. Kangari P.,Talaei-Khozani, T., Razeghian-Jahromi, I. & Razmkhah, M. Mesenchymal stem cells: amazing remedies for bone and cartilage defects. Stem Cell Res. Ther. 11, 492(2020).
104. Tan S. H.S. et al. Mesenchymal stem cell exosomes in bone regenerative strategies—a systematic review of preclinical studies. Mater. Today Bio 7, 100067 (2020).
105. Zhang, Y.et al.microRNA-935-modified bone marrow mesenchymal stem cellsderived exosomes enhance osteoblast proliferation and differentiation in osteoporotic rats. Life Sci. 272, 119204(2021).
106. Li, W.et al. Bone marrow mesenchymal stem cells derived exosomal Lnc TUG1 promotes bone fracture recovery via miR-22-5p/Anxa8 axis. Hum. Cell 36, 1041-1053 (2023).
107. Yang, J., Lei, P. & Wen, T. LncRNA MALAT1 shuttled by bone marrow-derived mesenchymal stem cells-secreted exosomes alleviates osteoporosis through mediating microRNA-34c/SATB2 axis. Aging 11, 8777-8791 (2019).
108. Zhang L., Wang Q., Su H.& Cheng, J. Exosomes from adipose derived mesenchymal stem cells alleviate diabetic osteoporosis in rats through suppressing NLRP3 inflammasome activation in osteoclasts. J. Biosci. Bioeng. 131, 671-678 (2021).
109. Zhang, X.et al.Extracellular vesicle-encapsulated miR-22-3p from bone marrow mesenchymal stem cell promotes osteogenic differentiation via FTO inhibition. Stem Cell Res. Ther. 11, 227(2020).
110. Jia Y., Qiu S., Xu J., Kang Q.& Chai, Y. Exosomes secreted by young mesenchymal stem cells promote new bone formation during distraction osteogenesis in older rats. Calcif. Tissue Int. 106, 509-517 (2020).
111. Xu, T.et al.Exosomal miRNA-128-3p from mesenchymal stem cells of aged rats regulates osteogenesis and bone fracture healing by targeting Smad5. J. Nanobiotechnol. 18, 47(2020).
112. Zhang, B.et al.Injectable composite hydrogel promotes osteogenesis and angiogenesis in spinal fusion by optimizing the bone marrow mesenchymal stem cell microenvironment and exosomes secretion. Mater. Sci. Eng. C. Mater. Biol. Appl. 123, 111782(2021).
113. Yang, S.et al.Integration of human umbilical cord mesenchymal stem cellsderived exosomes with hydroxyapatite-embedded hyaluronic acid-alginate hydrogel for bone regeneration. ACS Biomater. Sci. Eng. 6, 1590-1602 (2020).
114. Zhang, Y.et al.Exosomes from human umbilical cord mesenchymal stem cells enhance fracture healing through HIF-1α-mediated promotion of angiogenesis in a rat model of stabilized fracture. Cell Prolif. 52, e12570(2019).
115. Liu, W.et al.Hypoxic mesenchymal stem cell-derived exosomes promote bone fracture healing by the transfer of miR-126. Acta Biomater. 103, 196-212 (2020).
116. Zhang, S.et al. MSC exosomes mediate cartilage repair by enhancing proliferation, attenuating apoptosis and modulating immune reactivity. Biomaterials 156, 16-27 (2018).
117. Wei F., Li Z., Crawford R., Xiao Y.& Zhou, Y. Immunoregulatory role of exosomes derived from differentiating mesenchymal stromal cells on inflammation and osteogenesis. J. Tissue Eng. Regen. Med. 13, 1978-1991 (2019).
118. Hu L., Guan Z., Tang C., Li G.& Wen, J. Exosomes derived from microRNA-21 overexpressed adipose tissue-derived mesenchymal stem cells alleviate spine osteoporosis in ankylosing spondylitis mice. J. Tissue Eng. Regen. Med. 16, 634-642 (2022).
119. Chen, K.et al.Communications between bone marrow macrophages and bone cells in bone remodeling. Front. Cell Dev. Biol. 8, 598263(2020).
120. Kang, M.et al.Bone regeneration is mediated by macrophage extracellular vesicles. Bone 141, 115627 (2020).
121. Yu, L.et al.M1 macrophage-derived exosomes aggravate bone loss in postmenopausal osteoporosis via a microRNA-98/DUSP1/JNK axis. Cell Biol. Int. 45, 2452-2463 (2021).
122. Liu, K.et al.Macrophage-derived exosomes promote bone mesenchymal stem cells towards osteoblastic fate through microRNA-21a-5p. Front. Bioeng. Biotechnol. 9, 801432(2022).
123. Xiong, Y.et al.M2 Macrophagy-derived exosomal miRNA-5106 induces bone mesenchymal stem cells towards osteoblastic fate by targeting salt-inducible kinase 2 and 3. J. Nanobiotechnol. 18, 66(2020).
124. Pu, P.et al.Mechanical force induces macrophage-derived exosomal UCHL3 promoting bone marrow mesenchymal stem cell osteogenesis by targeting SMAD1. J. Nanobiotechnol. 21, 88(2023).
125. Wang Z., Zhao F., Zhao Y., Bai L.& Hang, R. Simultaneously enhanced osteogenesis and angiogenesis via macrophage-derived exosomes upon stimulation with titania nanotubes. Biomater. Adv. 134, 112708(2022).
126. Kusumbe, A. P., Ramasamy, S. K. & Adams, R. H. Coupling of angiogenesis and osteogenesis by a specific vessel subtype in bone. Nature 507, 323-328 (2014).
127. Seton-Rogers, S. Endothelial cells create a niche. Nat. Rev. Cancer 14, 298-298 (2014).
128. Wu, H.et al.Mechanism of vascular endothelial cell-derived exosomes modified with vascular endothelial growth factor in steroid-induced femoral head necrosis. Biomed. Mater. 18, 025017(2023).
129. Yang, R.-Z.et al.Exosomes derived from vascular endothelial cells antagonize glucocorticoid-induced osteoporosis by inhibiting ferritinophagy with resultant limited ferroptosis of osteoblasts. J. Cell. Physiol. 236, 6691-6705 (2021).
130. Lu J., Yang J., Zheng Y., Chen X.& Fang, S. Extracellular vesicles from endothelial progenitor cells prevent steroid-induced osteoporosis by suppressing the ferroptotic pathway in mouse osteoblasts based on bioinformatics evidence. Sci. Rep. 9, 16130(2019).
131. Chen, Y.et al.Exosomal Lnc NEAT1 from endothelial cells promote bone regeneration by regulating macrophage polarization via DDX3X/NLRP3 axis. J. Nanobiotechnol. 21, 98(2023).
132. Song, H.et al.Reversal of osteoporotic activity by endothelial cell-secreted bone targeting and biocompatible exosomes. Nano Lett. 19, 3040-3048 (2019).
133. Li, G.et al.Muscle-bone crosstalk and potential therapies for sarco-osteoporosis. J. Cell. Biochem. 120, 14262-14273 (2019).
134. Utvåg S. E., Grundnes O., Rindal, D. B. & Reikerås, O. Influence of extensive muscle injury on fracture healing in Rat Tibia. J. Orthop. Trauma 17, 430-435 (2003).
135. Qin W.& Dallas, S. L. Exosomes and extracellular RNA in muscle and bone aging and crosstalk. Curr. Osteoporos. Rep. 17, 548-559 (2019).
136. Huang, H.et al.Muscle-derived extracellular vesicles improve disuse-induced osteoporosis by rebalancing bone formation and bone resorption. Acta Biomater. 157, 609-624 (2023).
137. Takafuji, Y.et al.Extracellular vesicles secreted from mouse muscle cells suppress osteoclast formation: roles of mitochondrial energy metabolism. Bone 134, 115298 (2020).
138. Takafuji, Y.et al.MicroRNA-196a-5p in extracellular vesicles secreted from myoblasts suppresses osteoclast-like cell formation in mouse cells. Calcif. Tissue Int. 108, 364-376 (2021).
139. Li, Y.et al.Myoblast-derived exosomal Prrx2 attenuates osteoporosis via transcriptional regulation of lncRNA-MIR22HG to activate Hippo pathway. Mol. Med. 29, 54(2023).
140. Takada, Y.et al.Tumor Necrosis Factor-α blunts the osteogenic effects of muscle cell-derived extracellular vesicles by affecting muscle cells. Calcif. Tissue Int. 112, 377-388 (2023).
141. Fulzele, S.et al. Muscle-derived miR-34a increases with age in circulating extracellular vesicles and induces senescence of bone marrow stem cells. Aging 11, 1791-1803 (2019).
142. Goltzman D.Osteolysis and cancer. J. Clin. Investig. 107, 1219-1220 (2001).
143. Faict, S.et al.Exosomes play a role in multiple myeloma bone disease and tumor development by targeting osteoclasts and osteoblasts. Blood Cancer J. 8, 105(2018).
144. Raimondo, S.et al.Multiple myeloma-derived exosomes are enriched of amphiregulin (AREG) and activate the epidermal growth factor pathway in the bone microenvironment leading to osteoclastogenesis. J. Hematol. Oncol. 12, 2(2019).
145. Li, B.et al. Exosome-mediated transfer of lncRUNX2-AS1 from multiple myeloma cells to MSCs contributes to osteogenesis. Oncogene 37, 5508-5519 (2018).
146. Lin, L.et al.Osteosarcoma-derived exosomal miR-501-3p promotes osteoclastogenesis and aggravates bone loss. Cell. Signal. 82, 109935(2021).
147. Guo, L.et al.Breast cancer cell-derived exosomal miR-20a-5p promotes the proliferation and differentiation of osteoclasts by targeting SRCIN1. Cancer Med. 8, 5687-5701 (2019).
148. Wang M., Zhao M., Guo Q., Lou J.& Wang, L. Non-small cell lung cancer cell-derived exosomal miR-17-5p promotes osteoclast differentiation by targeting PTEN. Exp. Cell. Res. 408, 112834(2021).
149. Zhou, Y.et al.Exosomes derived from pancreatic cancer cells induce osteoclast differentiation through the miR125a-5p/TNFRSF1B Pathway. Onco Targets Ther. 14, 2727-2739 (2021).
150. Yun, B.et al.Short communication: dietary bovine milk-derived exosomes improve bone health in an osteoporosis-induced mouse model. J. Dairy Sci. 103, 7752-7760 (2020).
151. Hu, Y.et al. Extracellular vesicles from human umbilical cord blood ameliorate bone loss in senile osteoporotic mice. Metabolism 95, 93-101 (2019).
152. Zhang D., Du J., Yu M.& Suo, L. Urine-derived stem cells-extracellular vesicles ameliorate diabetic osteoporosis through HDAC4/HIF-1α/VEGFA axis by delivering microRNA-26a-5p. Cell Biol. Toxicol. 39, 2243-2257 (2023).
153. Chen, C. Y.et al.Extracellular vesicles from human urine-derived stem cells prevent osteoporosis by transferring CTHRC1 and OPG. Bone Res. 7, 18(2019).
154. Gatti, M.et al.Amniotic fluid stem cell-derived extracellular vesicles counteract steroid-induced osteoporosis in vitro. Int. J. Mol. Sci. 22, 38(2021).
155. Xu, X.et al.Intestinal microbiota: a potential target for the treatment of postmenopausal osteoporosis. Bone Res. 5, 17046(2017).
156. Liu, H.et al.Bone-targeted bioengineered bacterial extracellular vesicles delivering siRNA to ameliorate osteoporosis. Compos B Eng. 255, 110610(2023).
157. Liu, J.-H.et al.Extracellular vesicles from child gut microbiota enter into bone to preserve bone mass and strength. Adv. Sci. 8, 2004831(2021).
158. Li, P.et al.Metabolic alterations in older women with low bone mineral density supplemented with lactobacillus reuteri. J. Bone Miner. Res. 5, e10478(2021).
159. Yang, L.-C.et al.Lactobacillus plantarum GKM3 and Lactobacillus paracasei GKS6 supplementation ameliorates bone loss in ovariectomized mice by promoting osteoblast differentiation and inhibiting osteoclast formation. Nutrients 12, 1914 (2020).
160. Sapra, L.et al.Bifidobacterium longum ameliorates ovariectomy-induced bone loss via enhancing anti-osteoclastogenic and immunomodulatory potential of regulatory B cells (Bregs). Front. Immunol. 13, 875788(2022).
161. Liu, H.et al.Engineered bacterial extracellular vesicles for osteoporosis therapy. Chem. Eng. J. 450, 138309(2022).
162. Krishnan, N.et al.Bacterial membrane vesicles for vaccine applications. Adv. Drug Deliv. Rev. 185, 114294(2022).
163. Liu H., Fang G., Wu H., Li Z.& Ye, Q. L-Cysteine production in escherichia coli based on rational metabolic engineering and modular strategy. Biotechnol. J. 13, 1700695(2018).
164. Hwang, J.-H.et al. Yam-derived exosome-like nanovesicles stimulate osteoblast formation and prevent osteoporosis in mice. J. Control Release 355, 184-198 (2023).
165. Seo, K.et al. Ginseng-derived exosome-like nanovesicles extracted by sucrose gradient ultracentrifugation to inhibit osteoclast differentiation. Nanoscale 15, 5798-5808 (2023).
166. Park, Y.-S.et al.Plum-derived exosome-like nanovesicles induce differentiation of osteoblasts and reduction of osteoclast activation. Nutrients 15, 2107 (2023).
167. The effect of apple-derived nanovesicles on the osteoblastogenesis of osteoblastic MC3T3-E1 Cells. J. Med. Food 26, 49-58 (2023).
168. Boukouris S.& Mathivanan, S. Exosomes in bodily fluids are a highly stable resource of disease biomarkers. Proteomics Clin. Appl. 9, 358-367 (2015).
169. Katsuda, T., Kosaka, N. & Ochiya, T. The roles of extracellular vesicles in cancer biology: toward the development of novel cancer biomarkers. Proteomics 14, 412-425 (2014).
170. Lone, S. N.et al.Liquid biopsy: a step closer to transform diagnosis, prognosis and future of cancer treatments. Mol. Cancer 21, 79 (2022).
171. Nawaz, M.et al.The emerging role of extracellular vesicles as biomarkers for urogenital cancers. Nat. Rev. Urol. 11, 688-701 (2014).
172. Shi H., Jiang X., Xu C.& Cheng, Q. MicroRNAs in serum exosomes as circulating biomarkers for postmenopausal osteoporosis. Front. Endocrinol. 13, 819056(2022).
173. Huo, C.et al. Comparative proteomics analysis of microvesicles in human serum for the evaluation of osteoporosis. Electrophoresis 40, 1839-1847 (2019).
174. Chen, M.et al.Quantitative proteomics and reverse engineer analysis identified plasma exosome derived protein markers related to osteoporosis. J. Proteom. 228, 103940(2020).
175. Rody Jr, W. J. et al. Metabolomic signatures distinguish extracellular vesicles from osteoclasts and odontoclasts. Orthod. Craniofac. Res. 26, 632-641 (2023).
176. Zhi, F.et al.Exosomal hsa_circ_0006859 is a potential biomarker for postmenopausal osteoporosis and enhances adipogenic versus osteogenic differentiation in human bone marrow mesenchymal stem cells by sponging miR- 431-5p. Stem Cell Res. Ther. 12, 157(2021).
177. Zhao, K.et al.Hsa_Circ_0001275: a potential novel diagnostic biomarker for postmenopausal osteoporosis. Cell. Physiol. Biochem. 46, 2508-2516 (2018).
178. Zhang, Y.et al.Transfer RNA-derived fragments as potential exosome tRNAderived fragment biomarkers for osteoporosis. Int. J. Rheum. Dis. 21, 1659-1669 (2018).
179. Durdan, M. M., Azaria, R. D.& Weivoda, M. M. Novel insights into the coupling of osteoclasts and resorption to bone formation. Semin. Cell Dev. Biol. 123, 4-13 (2022).
180. Lu M.& Huang, Y. Bioinspired exosome-like therapeutics and delivery nanoplatforms. Biomaterials 242, 119925 (2020).
181. Man K., Brunet M. Y., Jones M.-C.& Cox, S. C. Engineered extracellular vesicles: tailored-made nanomaterials for medical applications. Nanomaterials 10, 1838 (2020).
182. Zhou, X.et al.Microreaction system combining chaotic micromixing with fast mixing and particle growth in liquid-segmented flow for the synthesis of hazardous ionic materials. Energetic Mater. Front. 1, 186-194 (2020).
183. Wang, J.et al.Bone-targeted exosomes: strategies and applications. Adv. Health. Mater. 12, 2203361(2023).
184. Lee, C.-S.et al.Bone-targeting exosome mimetics engineered by bioorthogonal surface functionalization for bone tissue engineering. Nano Lett. 23, 1202-1210 (2023).
185. Cui, Y.et al.A bone-targeted engineered exosome platform delivering siRNA to treat osteoporosis. Bioact. Mater. 10, 207-221 (2022).
186. Zheng, G.et al.Bone-targeting delivery of platelet lysate exosomes ameliorates glucocorticoid-induced osteoporosis by enhancing bone-vessel coupling. J. Nanobiotechnol. 20, 220(2022).
[187

Funding

Corresponding authors:Xiaoheng Liu ([e-mail]) or Chenchen Zhou ([e-mail])